批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/01/03 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
UNKNOWN
|
|
|
2021/03/08 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:THIOTEPA 剂型/给药途径:POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 规格:15MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
208264 |
001 |
NDA |
TEPADINA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
15MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2017/01/26
|
ADIENNE SA |
213049 |
001 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
15MG/VIAL |
Prescription |
No |
No |
AP |
2020/03/04
|
MSN |
214222 |
001 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
15MG/VIAL |
Prescription |
No |
No |
AP |
2021/03/08
|
GLAND PHARMA LTD |
216037 |
001 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
15MG/VIAL |
Prescription |
No |
No |
AP |
2023/12/26
|
MEITHEAL |
217559 |
001 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
15MG/VIAL |
Prescription |
No |
No |
AP |
2024/08/20
|
BELOTECA |
活性成分:THIOTEPA 剂型/给药途径:POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL 规格:100MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
208264 |
002 |
NDA |
TEPADINA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
100MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2017/01/26
|
ADIENNE SA |
213049 |
002 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
100MG/VIAL |
Prescription |
No |
No |
AP |
2020/03/04
|
MSN |
214222 |
002 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
100MG/VIAL |
Prescription |
No |
No |
AP |
2022/01/03
|
GLAND PHARMA LTD |
211755 |
001 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
100MG/VIAL |
Prescription |
No |
No |
AP |
2023/09/05
|
HIKMA |
216037 |
002 |
ANDA |
THIOTEPA |
THIOTEPA |
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
100MG/VIAL |
Prescription |
No |
No |
AP |
2023/12/26
|
MEITHEAL |